Publications by authors named "Tiphaine Kermarrec"
Background: Colorectal cancer (CRC) screening using fecal immunochemical testing (FIT) aims to detect pre-symptomatic colorectal lesions and reduce CRC mortality.
Aims: The objectives of this study were to determine the FIT sensitivity for diagnosis of CRC, the impact of diagnostic circumstances on treatment and survival, and risk factors for interval cancer (IC).
Methods: This population-based study evaluated the 2016-2017 CRC screening campaign in Finistère, France.
Pancreatic cancer is associated with high mortality rates, and most cases are diagnosed at advanced stages. This study aimed to evaluate the prognostic factors for survival in pancreatic adenocarcinoma. Data from the Finistere registry of digestive database were used in this analysis.
View Article and Find Full Text PDFArticle Synopsis
- Survival rates for colon cancer patients have improved due to better treatments and the use of multidisciplinary team meetings (MDTm), but the organization of these meetings can still be optimized.
- A study of 1,616 patients diagnosed between 2014 and 2016 found that 20.5% were not presented in MDTm, mainly due to factors like advanced age, poor condition, and superficial tumors.
- Identifying these non-presentation factors can help target improvements in MDTm organization and ensure more comprehensive patient care.
Aim: Oncological strategies in the elderly population are often debated. The objective of this study was to investigate the survival rates and prevalence of ostomy in elderly patients operated on for stage III and IV rectal cancers.
Methods: This retrospective multicentric population-based study included 151 patients aged ≥75 years with stage III and IV rectal adenocarcinoma who underwent surgery between 2007 and 2014.
Purpose: Oncological strategies in the elderly population are debated. The objective of this study was to assess the factors predictive of poor prognosis in elderly patients with stage III colon cancer.
Methods: A retrospective review of demographic, pathologic, treatment, and outcome data from 308 patients with stage III colon adenocarcinoma who had undergone surgery between 2007 and 2014 was conducted.
Objective: The aim of this study was to compare quality performance of the first colorectal cancer (CRC) screening campaigns (C) with the OC Sensor® Faecal Immunological Test (FIT) (C7 from 2016 to 2017) and the Hemoccult® guaiac-based test (C1 from 2004 to 2006).
Methods: The participation rate of the eligible population, screening fecal occult blood test (FOBT) performance indices, CRC and adenoma detection rate and time interval between test positivity and colonoscopy were studied.
Results: In C7, 35.
The therapeutic management of patients with endoscopic resection of colorectal cancer invading the submucosa (i.e. pT1 CRC) depends on the balance between the risk of cancer relapse and the risk of surgery-related morbidity and mortality.
View Article and Find Full Text PDFArticle Synopsis
- This study looks at how doctors can tell if patients with early colorectal cancer (pT1 CRC) need more surgery by checking for cancer risks like lymph node invasion and tumor recurrence.
- Two pathologists reviewed 163 cases from a database in France, looking at specific factors based on guidelines.
- They found that using certain types of tests made it easier for doctors to agree on the risk levels, especially for lymphovascular invasion and tumor budding, which helps decide if additional surgery is necessary.